HomeQuestion
Do you ever extend adjuvant imatinib for patients with high-risk, localized GIST beyond 3 years?
2 Answers
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center
The NCCN guidelines appropriately recommend "at least 3 yrs" of adjuvant Imatinib in intermediate to high risk, resected GIST. The decision to continue longer becomes a personalized one based on risk of recurrence, tolerance to Imatinib, coverage, etc. There are scenarios where both, the provider an...